SPDL1 and melanoma: In fact, increased sPD-L1 levels have been associated with worse prognosis in a wide variety of tumors such as diffuse large B cell lymphoma, T cell lymphoma, multiple myeloma, oral squamous cell carcinoma, melanoma and hepatocellular carcinoma [11].